Valley wants our patients and community to be on the alert against medical billing scams. Learn how to protect yourself and your personal information from scammers posing as hospital representatives.Read More
Remedē® System Therapy Registry (rēST Registry)
The objective of this study is to collect clinical data on the safety and effectiveness of the remedē System in a real-world setting.
Subjects who are determined to be candidates to receive a de novo commercial implant of the remedē System are eligible for inclusion in this trial, subject to the entry criteria.
- Moderate to severe central sleep apnea (AHI > 15 events per hour with the events being predominantly central in origin) based on a PSG within 12 months of expected implant date scored by a local sleep laboratory.
- Not currently enrolled in another investigational study or registry that would directly interfere with the current study, except if the subject is participating in a mandatory government registry, or a purely observational registry with no associated treatments. Each instance should be brought to the attention of the sponsor to determine eligibility.